https://pubmed.ncbi.nlm.nih.gov/29211816/
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer...
A subgroup of long responder patients to regorafenib treatment was identified and a comprehensive molecular characterisation was performed; however, further...
clinical outcomemolecularcharacterisationmetastaticcolorectal
https://open.library.emory.edu/concern/publications/d5545e11-dd23-4ce0-9ea5-edb9e77f251b
Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory...
Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases
genomicmutationsbiomarkersradioembolization